IPO - Radiopharm Theranostics Limited - 25 November 2021 11:00 AM AEDT ##, page-78

And don't forget out of 77m as per Prospectus

$4m is IPO cost
$27m will be paid for licences

I think more then hype it was overall sentiment issue with Biotech IPO after TRP and everyone got a good allocation that itself was bit of red flag

people bang on about CU6 but CU6 opened above IPO price and was there for week at least and pre IPo and IPO participants would have made money plus they own the rights to IP where as RAD has raised money to bring together 7 products under pipeline and paying licences (fair few companies do that)

And Don't forget TLX is almost there in generating revenue from there Radiotherapy products which is still doing fine in terms of valuation that CU6 and RAD is following in terms of foot steps


Disc Holding here from Pre IPO and IPO